AbbVie · 2 days ago
Senior Director, R&D Quality Transformation and Data Science
AbbVie is dedicated to delivering innovative medicines and solutions that address serious health issues. The Senior Director, R&D Quality Transformation and Data Science will lead the transformation across R&D Quality Assurance, integrating digital and analytics to optimize quality processes and foster a culture of excellence.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Develop, own, and continuously evolve the long-term strategy and roadmap for R&D QA transformation—including advanced analytics, AI/ML, process optimization, and operational excellence—anchored to organization-wide priorities, regulatory requirements, and diagnostic insights
Evaluate and translate survey and diagnostic findings into prioritized change initiatives addressing root causes and opportunities for improvement in both quality culture and business operations
Lead high-performing, multi-layered global matrixed teams (senior leaders, directors, managers, and technical experts) to deliver advanced analytics, enable digital transformation, and reimagine processes across the R&D QA landscape
Champion investments and adoption of new technologies, platforms, and operating models that drive operational efficiency, data-driven decision making, and sustained quality improvement
Oversee alignment and execution of cross-functional, enterprise-level analytics and transformation projects, including resource planning, budget ownership, measurable outcomes, and ongoing stakeholder engagement
Set policy and governance for data quality, analytics compliance, AI/ML usage, and change management, ensuring all enhancements meet regulatory and business standards
Advise senior leaders on risks, impacts, and opportunities related to QA transformation, digital strategies, and emerging regulatory trends
Build partnerships across IT, R&D, Regulatory, and Business functions—promoting a culture of innovation, collaboration, and transparency
Represent R&D QA internally and externally, advancing quality analytics, process excellence, and talent development
Promote continuous learning, diversity, and upskilling to support evolving business and digital needs
Qualification
Required
Advanced degree in Data Science, Engineering, Quality, Business, Life Sciences, or related discipline
12+ years progressive leadership in data science, analytics, AI/ML, process transformation, or operational excellence within life sciences or regulated industries, including leadership of large, multi-disciplinary global teams
15+ years industry experience across pharmaceutical, medical device, combination products, research, development, clinical operations, manufacturing, quality systems, or comparable experiences
Demonstrated success leading large-scale, enterprise transformation initiatives leveraging advanced analytics, digital/AI/ML technologies, and survey-driven insights to impact quality and business outcomes
Deep expertise in R&D quality systems, global compliance, process optimization, and digital innovation in regulated environments
Strong executive presence, strategic vision, budget/resource management, and proven ability to lead and influence cross-functional teams
Outstanding communication, change leadership, and stakeholder management skills
Track record of delivering measurable business impact through process, digital, and analytics innovation
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-09
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase